Heart failure is a common, costly and potentially fatal condition in which the heart can’t pump enough blood to meet the body’s needs. Current options for patients with end-stage heart failure includes mechanical support devices and heart transplants. Alternatively, engineered heart muscle may offer new avenues to repair the failing heart.
Together with the University Medical Center Göttingen, the German Primate Center Göttingen and the Leibniz University in Hannover, the Max Planck Institute for Dynamics and Self-Organization (MPIDS) is the second winner in the nationwide innovation competition "Organ Replacement from the Laboratory" of the Federal Ministry of Education and Research with its IndiHEART project. The name IndiHEART stands for "Individualised heart muscle for the functional treatment of heart failure". This project is supported with 2 Million Euros over three years, starting from 2022.
Within this project, the LFPB group focuses on the cardiac modeling and the development of special printing processes for the production of individualized heart patches. For more details, please also refer to https://www.ds.mpg.de/3589595/200520_indiheart .